$FIVN

Q2 earnings for video conferencing stocks showed revenue growth of 2% above estimates. RingCentral (RNG) reported $657M in revenue, up 5.9% YoY, beating expectations. 8x8 (EGHT) saw 4.9% YoY growth, exceeding estimates by 4.3%. Five9 (FIVN) grew 10.3% YoY, beating estimates by 1.9%. Zoom (ZM) reported $1.28B in revenue, up 4.9% YoY, surpassing expectations by 0.7%.

NovelVox, an AI and unified agent experience provider, achieved Select ISV Partner status with Five9 (FIVN), enabling direct sales of its solutions to joint customers. The partnership streamlines integration of Five9's Intelligent CX Platform with core systems in banking, credit unions, and healthcare, improving agent productivity and customer experience. NovelVox offers pre-built integrations with platforms like Jack Henry, Fiserv, and Oracle Health.

Five9 (FIVN) reported Q2 revenue of $312.4M, up 10.3% YoY, beating estimates by 1.9%. Despite mixed results, its stock rose 22.9%. RingCentral (RNG) saw revenue increase 5.9%, stock up 106%. Zoom (ZM) reported $1.28B revenue, up 4.9%, but stock fell 6.8%. 8x8 (EGHT) beat estimates with 4.9% revenue growth, stock flat. Video conferencing stocks averaged 30.5% gains post-earnings.

The AI ROI in Contact Center Summit featured executives from Cisco, Five9, Zoom, and Talkdesk discussing AI in customer experience. Key points included the need to move beyond basic AI agents to more complex, enterprise-grade solutions, the shift away from metrics like containment and deflection, and the importance of orchestration in AI deployment. Five9's research showed a perception gap between businesses and customers regarding contact center improvements.

Five9 (FIVN) President Andy Dignan sold 6,986 shares at $35.00 each on Sept. 17, 2026, totaling $244,510. He retains 237,614 shares, valued at ~$8.8M post-transaction. The sale was part of a Rule 10b5-1 plan adopted in 2025. Five9's stock has a 33% one-year return, with a market cap of $2.9B and TTM revenue of $1.2B.

Analysts made several rating changes: Wolfe upgraded Paychex (PAYX) citing stable employment trends. UBS upgraded Union Pacific (UNP) to Buy with a $339 price target, expecting strong 2027 volume growth. Needham upgraded Rocket Pharmaceuticals (RCKT) to Buy with a $9 target after FDA reaffirmed study design. JPMorgan upgraded Credicorp (BAP) to Overweight with a $482 target, seeing strong EPS growth. Morgan Stanley downgraded Expedia (EXPE) to Underweight with a $235 target, citing weaker assets

Wall Street analysts upgraded Credicorp (BAP) to Overweight, Paychex (PAYX) to Peer Perform, Rocket Pharmaceuticals (RCKT) to Buy, Similarweb (SMWB) to Buy, and Union Pacific (UNP) to Buy. Downgrades include Expedia (EXPE) to Underweight, Grupo Aval (AVAL) to Underweight, Hartford Financial (HIG) to Neutral, Meritage Homes (MTH) to Hold, and Nubank (NU) to Market Perform. Initiations: Airbnb (ABNB) with Equal Weight, Booking Holdings (BKNG) with Overweight, Dutch Bros (BROS) with Buy, Five9 (FIV

Lee Bryan M (Chief Financial Officer) sold 20,618 shares of Five9, Inc. (FIVN) at an average of $33.30 ($32.60–$33.52, $0.69M total) across 4 trades over 2026-09-04 to 2026-09-08 under a Rule 10b5-1 trading plan.

Meriweather Tiffany N. (Chief Admin. & Legal Officer) sold 18,523 shares of Five9, Inc. (FIVN) at an average of $32.82 ($31.55–$33.51, $0.61M total) across 3 trades over 2026-09-04 to 2026-09-08 under a Rule 10b5-1 trading plan.

Five9 (FIVN) shares hit a 52-week high of $35.18, up 20.2% over the past month and 70.1% year-to-date. The company has beaten earnings estimates for four consecutive quarters. Analysts expect FY2026 EPS of $3.25 on revenue of $1.27B, with a Zacks Rank of #2 (Buy). Paycom Software (PAYC) is also highlighted as a strong performer in the industry.